Status:
RECRUITING
Tranexamic Acid in Traumatic Brain Injury
Lead Sponsor:
Assiut University
Conditions:
Inflammatory Response
Eligibility:
All Genders
18-65 years
Phase:
PHASE3
Brief Summary
In this study, our aim is to investigate the role of tranexamic acid for modulating the inflammation in patients with traumatic brain injury (TBI).
Detailed Description
This is double-blind trial, where group T will be received TXA, where group C will be received saline placebo. In emergency room (ER), trauma patients will be assessed and managed according to our lo...
Eligibility Criteria
Inclusion
- Isolated traumatic brain injury patients (mild or moderate cases)
- GCS \> 8
- non penetrating TBI in 8 hours onset
- Age ≥ 18 years
Exclusion
- Patient in cardiac arrest
- Patients with coagulopathies
- Renal failure patients
- pregnancy
- Patient refusal to participate
Key Trial Info
Start Date :
May 18 2022
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
October 15 2027
Estimated Enrollment :
60 Patients enrolled
Trial Details
Trial ID
NCT05323149
Start Date
May 18 2022
End Date
October 15 2027
Last Update
January 2 2026
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Assiut university hospital
Asyut, Assuit, Egypt, Assuit universi